WV Board of Pharmacy

WV Pharmacy Board Adopts CDC COVID-19 Vaccine Recommendations

The West Virginia Board of Pharmacy has adopted the CDC's recommendations for the 2025-2026 COVID-19 vaccines. This guidance allows pharmacists, technicians, and interns to administer vaccines to individuals aged 3 years and older, based on individual decision-making and CDC risk factor guidelines.

WV Board of Pharmacy Warns of Phone Scam Targeting Licensees

The West Virginia Board of Pharmacy has issued a warning regarding a phone scam targeting its licensees. Scammers are impersonating Board investigators, claiming disciplinary action and attempting to solicit payment over the phone. The Board reminds licensees that it will never request payment in lieu of an investigation.

DEA Extends Telemedicine Flexibilities for Controlled Medications

The DEA, in conjunction with HHS, has extended current telemedicine flexibilities for prescribing controlled medications through December 31, 2026. This allows DEA-registered practitioners to remotely prescribe Schedule II-V controlled medications, including certain narcotic medications for opioid use disorder treatment, without a prior in-person evaluation.

WV Board of Pharmacy CSMP Modernization to RxGov System

The West Virginia Board of Pharmacy is modernizing its Controlled Substances Monitoring Program (CSMP) by transitioning from the CSAPP platform to the RxGov system. This upgrade aims to improve performance, data quality, and reporting capabilities. Key transition dates are outlined, with a full cutover expected in early March 2026.